COVID-19, Diabetes and Ramadan Tahseen A. ChowdhurySalman WaqarNazim Ghouri Commentary Open access 03 September 2020 Pages: 2447 - 2451
Looping with Do-It-Yourself Artificial Pancreas Systems During Ramadan Fasting in Type 1 Diabetes Mellitus: Perspectives of a User and a Physician Syed Haris AhmedSaira Gallo Commentary Open access 09 September 2020 Pages: 2453 - 2463
Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes David MatthewsStefano Del PratoPäivi Maria Paldánius Commentary Open access 25 September 2020 Pages: 2465 - 2476
Ramadan and Diabetes: A Narrative Review and Practice Update Syed H. AhmedTahseen A. ChowdhuryNazim Ghouri Review Open access 09 September 2020 Pages: 2477 - 2520
Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes Zhiwei ZengShi-Ying HuangTao Sun Review Open access 15 September 2020 Pages: 2521 - 2538
Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review Vincent WooLori BerardRobert Roscoe Review Open access 17 September 2020 Pages: 2539 - 2553
The Safety and Efficacy of Second-Generation Basal Insulin Analogues in Adults with Type 2 Diabetes at Risk of Hypoglycemia and Use in Other Special Populations: A Narrative Review Alice Y. Y. ChengJencia WongElif Ekinci Review Open access 25 September 2020 Pages: 2555 - 2593
Insulin Injection Practices in a Population of Canadians with Diabetes: An Observational Study Basel BariMarie-Andrée CorbeilLori Berard Original Research Open access 07 September 2020 Pages: 2595 - 2609
Impact of Liver Cirrhosis on Incidence of Dialysis Among Patients with Type 2 Diabetes Yi-Jing SheenPei-Tseng KungWen-Chen Tsai Original Research Open access 08 September 2020 Pages: 2611 - 2628
Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study Xuejun Victor PengRory J. McCrimmonLawrence Blonde Original Research Open access 09 September 2020 Pages: 2629 - 2645
Continuous Lumbar Sympathetic Blockade Enhances the Effect of Lumbar Sympatholysis on Refractory Diabetic Neuropathy: A Randomized Controlled Trial Haiyan SunMingwei HeJun Ma Original Research Open access 11 September 2020 Pages: 2647 - 2655
Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data Michael WillisChristian AsseburgCheryl Neslusan Original Research Open access 15 September 2020 Pages: 2657 - 2676
ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide Antonio C. BossiValentina De Morithe ANDREW study group Original Research Open access 24 September 2020 Pages: 2677 - 2690
Association Between Fasting Blood Glucose and All-Cause Mortality in a Rural Chinese Population: 15-Year Follow-Up Cohort Study Nannan ChengYue ZhangXiping Xu Original Research Open access 25 September 2020 Pages: 2691 - 2701
Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis Paramesh ShamannaBanshi SabooMohamed Thajudeen Original Research Open access 25 September 2020 Pages: 2703 - 2714
Periodontal Disease in Diabetes Mellitus: A Case–Control Study in Smokers and Non-Smokers Emese BattancsDorottya GheorghitaMárk Antal Original Research Open access 25 September 2020 Pages: 2715 - 2728
A Prospective Longitudinal Study on the Relationship Between Glucose Fluctuation and Cognitive Function in Type 2 Diabetes: PROPOSAL Study Protocol Masaki MatsubaraHisashi MakinoKiminori Hosoda Study Protocol Open access 05 September 2020 Pages: 2729 - 2737
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design Shinya FujikiKenichi Iijimathe EMPA-ICD investigators Study Protocol Open access 23 September 2020 Pages: 2739 - 2755